City

Bethesda (1)

Brescia (1)

Rome (1)

Toronto (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Unknown status (1)

Phase

phase 1 (2)

phase 2 (1)

Sponsor

GAAD Medical Research Institute Inc. (1)

I.R.C.C.S. Fondazione Santa Lucia (1)

National Institute of Neurological Disorders and Stroke (NINDS) (1)

Collaborator

Alzheimer's Drug Discovery Foundation (1)

Intervention

direct current polarization (1)

placebo (1)

radiation: far infrared radiation (5μm to 20μm wavelength) (1)

rotigotine 4mg/24hrs patch (1)

rotigotine 6mg/24hrs patch (1)

Study Documents

Intervention Type

drug (1)

procedure (1)

radiation (1)

Funder Type

Other (2)

NIH (1)

Study Type

Interventional (3)

pick disease of the brain

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Frontotemporal Dementia, Dementia, Aphasia, Primary Progressive Trial in Brescia, Rome (Rotigotine 4Mg/24Hrs Patch, Rotigotine

Active, not recruiting

Frontotemporal Dementia
+19 more

Rotigotine 4Mg/24Hrs Patch
+2 more

Brescia, Italy
+2 more

Jul 7, 2022

Pick Disease of the Brain Trial in Toronto (Radiation: Far Infrared Radiation (5µm to 20µm wavelength))

Unknown status

Pick Disease of the Brain

Radiation: Far Infrared Radiation (5μm to 20μm wavelength)

Toronto, Ontario, Canada

The Centre for Incurable Diseases

Aug 14, 2009

Pick Disease of the Brain Trial run by the NINDS (Direct Current Polarization)

Completed

Pick Disease of the Brain

Direct Current Polarization

Bethesda, Maryland

National Institute of Neurological Disorders and Stroke (NINDS)

Mar 3, 2008